Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Overview of Castleman disease
Castleman disease (CD) describes a group of at least 4 disorders that share a spectrum of
characteristic histopathological features but have a wide range of etiologies, presentations …
characteristic histopathological features but have a wide range of etiologies, presentations …
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
Castleman disease (CD) describes a group of heterogeneous hematologic disorders with
characteristic histopathological features. CD can present with unicentric or multicentric …
characteristic histopathological features. CD can present with unicentric or multicentric …
Castleman disease
Castleman disease (CD), a heterogeneous group of disorders that share morphological
features, is divided into unicentric CD and multicentric CD (MCD) according to the clinical …
features, is divided into unicentric CD and multicentric CD (MCD) according to the clinical …
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus
Within weeks of the first report of acquired immunodeficiency syndrome (AIDS) in 1981, it
was observed that these patients often had Kaposi sarcoma (KS), a hitherto rarely seen skin …
was observed that these patients often had Kaposi sarcoma (KS), a hitherto rarely seen skin …
Assessment of the safety of pembrolizumab in patients with HIV and advanced cancer—a phase 1 study
TS Uldrick, PH Gonçalves, M Abdul-Hay… - JAMA …, 2019 - jamanetwork.com
Importance Anti− PD-1 (anti− programmed cell death 1) and anti− PD-L1 (anti− programmed
cell death ligand 1) regimens are preferred therapies for many cancers, including cancers …
cell death ligand 1) regimens are preferred therapies for many cancers, including cancers …
Systematic review of safety and efficacy of rituximab in treating immune-mediated disorders
C Kaegi, B Wuest, J Schreiner, UC Steiner… - Frontiers in …, 2019 - frontiersin.org
Background: During the past years biologic agents (also termed biologicals or biologics)
have become a crucial treatment option in immunological diseases. Numerous articles have …
have become a crucial treatment option in immunological diseases. Numerous articles have …
KSHV/HHV8-mediated hematologic diseases
E Cesarman, A Chadburn… - Blood, The Journal of …, 2022 - ashpublications.org
Kaposi sarcoma (KS) herpesvirus (KSHV), also known as human herpesvirus 8, is the
causal agent of KS but is also pathogenetically related to several lymphoproliferative …
causal agent of KS but is also pathogenetically related to several lymphoproliferative …
The full spectrum of Castleman disease: 273 patients studied over 20 years
E Oksenhendler, D Boutboul… - British Journal of …, 2018 - Wiley Online Library
The spectrum of Castleman disease (CD) has considerably extended since its first
description in 1956. Recently, an international collaborative working group has reached …
description in 1956. Recently, an international collaborative working group has reached …
Hematologic cancers in individuals infected by HIV
A Carbone, E Vaccher… - Blood, The Journal of the …, 2022 - ashpublications.org
HIV infection increases cancer risk and is linked to cancers associated to infectious agents
classified as carcinogenic to humans by the International Agency for Research on Cancer …
classified as carcinogenic to humans by the International Agency for Research on Cancer …
Diagnosis and management of Castleman disease
JD Soumerai, AR Sohani, JS Abramson - Cancer control, 2014 - journals.sagepub.com
Background Castleman disease is an uncommon lymphoproliferative disorder characterized
as either unicentric or multicentric. Unicentric Castleman disease (UCD) is localized and …
as either unicentric or multicentric. Unicentric Castleman disease (UCD) is localized and …